Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
International Political Science Review
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lanoszka, A.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Global Politics of Intellectual Property Rights and Pharmaceutical Drug Policies in Developing Countries

Anna Lanoszka

One of the major characteristics of the emerging international economic order is the treatment of intellectual property rights (iprs). Developing country Members are very concerned about the impact that the World Trade Organization (wto) Agreement on Trade-Related Aspects of Intellectual Property Rights (trips) will have on their economies. Of particular concern are those aspects of the Agreement that relate to the issue of access to new pharmaceutical inventions. trips emphasizes a property rights approach whereby private "owners" of the inventions can restrict access on the basis of commercial considerations. As a consequence, higher prices for pharmaceuticals and other healthcare inventions can prevent low-income consumers in developing countries from obtaining life-saving medications and equipment. It is true, of course, that exploitative business practices are possible only to the extent that monopoly positions are tolerated. Many developing countries, however, lack the necessary financial resources and have not yet developed appropriate competition rules to deal effectively with the challenges presented by the trips Agreement.

Key Words: Access to affordable medicines • Developing countries • trips Agreement • wto

International Political Science Review, Vol. 24, No. 2, 181-197 (2003)
DOI: 10.1177/0192512103024002002


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Global Social PolicyHome page
W. Hein and L. Kohlmorgen
Global Health Governance: Conflicts on Global Social Rights
Global Social Policy, April 1, 2008; 8(1): 80 - 108.
[Abstract] [PDF]